Company Valuation: Bio-Rad Laboratories, Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 22,439 12,460 9,399 9,182 8,212 7,885 - -
Change - -44.47% -24.57% -2.31% -10.57% -3.98% - -
Enterprise Value (EV) 1 22,439 11,868 8,992 8,730 7,874 7,136 6,920 6,779
Change - -47.11% -24.24% -2.91% -9.8% -9.37% -3.03% -2.04%
P/E Ratio 5.38x - -14.8x -5.03x 10.9x 35.1x 34.4x 34.6x
PBR - 1.27x 1.05x 1.41x 1.11x 1.13x 1.09x -
PEG - - - -0x -0x -0.5x 15.06x -49.07x
Capitalization / Revenue 7.68x 4.45x 3.52x 3.58x 3.18x 3.07x 2.99x 2.95x
EV / Revenue 7.68x 4.24x 3.37x 3.4x 3.05x 2.78x 2.63x 2.53x
EV / EBITDA 33.1x 17.8x 16.8x 18.2x 17.4x 17.9x 16.2x 15.3x
EV / EBIT 39.3x 22.7x 23.7x 26.4x 25.3x 26.8x 23.2x 21.1x
EV / FCF 41.9x 127x 24x - - 22.9x 22.1x 20.8x
FCF Yield 2.39% 0.79% 4.17% - - 4.37% 4.53% 4.81%
Dividend per Share 2 - - - - - - - -
Rate of return - - - - - - - -
EPS 2 140.6 - -21.82 -65.36 27.85 8.32 8.51 8.45
Distribution rate - - - - - - - -
Net sales 1 2,923 2,802 2,671 2,566 2,583 2,567 2,635 2,676
EBITDA 1 677.5 667.9 535.9 479.5 453.2 398.6 426.3 442.3
EBIT 1 571.2 524 378.9 331.3 311.6 266.8 298 322
Net income 1 4,246 -3,628 -637.3 -1,844 759.9 224.8 229.7 228.3
Net Debt 1 - -592.5 -407.6 -452.1 -337.7 -749 -965.4 -1,107
Reference price 2 755.57 420.49 322.89 328.51 302.99 292.44 292.44 292.44
Nbr of stocks (in thousands) 29,918 29,824 29,145 27,997 26,975 26,762 - -
Announcement Date 2/10/22 2/16/23 2/15/24 2/13/25 2/12/26 - - -
1USD in Million2USD
Estimates

P/E Ratio, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
34.98x2.77x17.83x-.--% 7.85B
22.43x3.32x12.49x2.85% 155B
20.17x3.48x12.52x3.56% 103B
14.82x0.18x11.11x0.84% 54.72B
35.03x8.65x23.28x1.1% 53.65B
36.82x2.95x10.13x2.61% 40.72B
34.98x1.3x11.43x0.22% 30.9B
30.55x5.45x17.4x-.--% 28.85B
39.3x6.8x24.52x0.27% 23.38B
24.9x3.17x12.94x1.3% 21.22B
Average 29.40x 3.81x 15.36x 1.28% 51.97B
Weighted average by Cap. 25.85x 3.68x 14.13x 2.04%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. BIO Stock
  4. Valuation Bio-Rad Laboratories, Inc.
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!